Aldehyde-mediated inhibition of asparagine biosynthesis has implications for diabetes and alcoholism.

作者信息

John Tobias, Saffoon Nadia, Walsby-Tickle John, Hester Svenja S, Dingler Felix A, Millington Christopher L, McCullagh James S O, Patel Ketan J, Hopkinson Richard J, Schofield Christopher J

机构信息

Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford 12 Mansfield Road Oxford OX1 3TA UK

Nuffield Department of Medicine, Target Discovery Institute, University of Oxford Oxford UK.

出版信息

Chem Sci. 2024 Jan 15;15(7):2509-2517. doi: 10.1039/d3sc06551k. eCollection 2024 Feb 14.

Abstract

Patients with alcoholism and type 2 diabetes manifest altered metabolism, including elevated aldehyde levels and unusually low asparagine levels. We show that asparagine synthetase B (ASNS), the only human asparagine-forming enzyme, is inhibited by disease-relevant reactive aldehydes, including formaldehyde and acetaldehyde. Cellular studies show non-cytotoxic amounts of reactive aldehydes induce a decrease in asparagine levels. Biochemical analyses reveal inhibition results from reaction of the aldehydes with the catalytically important N-terminal cysteine of ASNS. The combined cellular and biochemical results suggest a possible mechanism underlying the low asparagine levels in alcoholism and diabetes. The results will stimulate research on the biological consequences of the reactions of aldehydes with nucleophilic residues.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7533/10866355/11947965101d/d3sc06551k-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索